ABEO
Abeona Therapeutics Inc.
6.12
4 x 4.47
2 x 7.83
bid
ask
+
0.07
1.18%
11:24 AM
timesize
| Ytd | 16.15% | |
| 1y | 4.28% |
6.00
day range
6.26
4.00
52 week range
7.54
| Open | 6.18 | Prev Close | 6.05 | Low | 6.00 | High | 6.26 | Mkt Cap | 349.10M |
| Vol | 462.42K | Avg Vol | 1.15M | EPS | 0.95 | P/E | 6.45 | Forward P/E | -3.84 |
| Beta | 1.50 | Short Ratio | 10.79 | Inst. Own | 77.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 5.61 | 200-d Avg | 5.20 | 1yr Est | 16.75 |
| Income Statement | |||
| Total Revenue | 8.72M | ||
| Revenues (USD) | 8.72M | ||
| Cost of Revenue | 2.70M | ||
| Gross Profit | 6.02M | ||
| Operating Expenses | 29.06M | ||
| Research and Development Expense | 9.56M | ||
| Selling, General and Administrative Expense | 19.50M | ||
| Operating Income | -23.03M | ||
| Interest Expense | 830.00K | ||
| Income Tax Expense | 2.00K | ||
| Net Income | -17.07M | ||
| Net Income Common Stock | -17.07M | ||
| Net Income Common Stock (USD) | -17.07M | ||
| Consolidated Income | -17.07M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -16.24M | ||
| Earning Before Interest & Taxes (USD) | -16.24M | ||
| Weighted Average Shares | 56.62M | ||
| Weighted Average Shares Diluted | 56.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.37M | ||
| Cash and Equivalents (USD) | 61.37M | ||
| Investments | 106.90M | ||
| Investments Current | 106.90M | ||
| Trade and Non-Trade Receivables | 6.71M | ||
| Current Assets | 182.99M | ||
| Property, Plant & Equipment Net | 14.68M | ||
| Total Assets | 198.49M | ||
| Debt Current | 14.61M | ||
| Total Debt | 23.17M | ||
| Current Liabilities | 31.05M | ||
| Debt Non-Current | 8.57M | ||
| Total Liabilities | 53.56M | ||
| Accumulated Retained Earnings (Deficit) | -759.15M | ||
| Accumulated Other Comprehensive Income | -21.00K | ||
| Shareholders Equity | 144.94M | ||
| Shareholders Equity (USD) | 144.94M | ||
| Assets Non-Current | 15.51M | ||
| Total Debt (USD) | 23.17M | ||
| Deferred Revenue | 425.00K | ||
| Inventory | 6.05M | ||
| Liabilities Non-Current | 22.51M | ||
| Trade and Non-Trade Payables | 11.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 869.00K | ||
| Net Cash Flow from Financing | -2.22M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.06M | ||
| Capital Expenditure | -935.00K | ||
| Issuance (Repayment) of Debt Securities | -2.22M | ||
| Net Cash Flow from Investing | 4.96M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.90M | ||
| Net Cash Flow from Operations | -19.80M | ||
| Share Based Compensation | 2.96M | ||